Anaplastic thyroid cancer (ATC) is a rare malignancy. While external beam radiation therapy
has improved locoregional control, the median survival of∼ 4 months has not changed in …

Abstract Purpose of Review Anaplastic thyroid carcinoma is a type of thyroid carcinoma with
the most aggressive biological behaviour amongst thyroid cancer. Here, we review the …

Anaplastic thyroid carcinoma (ATC) is a rare malignancy, accounting for 1–2% of all thyroid
cancers. Although rare, ATC accounts for the majority of deaths from thyroid carcinoma. ATC …

Anaplastic thyroid carcinoma ranges from 1.3 to 9.8% of all thyroid cancers globally.
Mutations, amplifications, activation of oncogenes and silencing of tumour suppressor genes …

Anaplastic thyroid cancer (ATC) is one of the most lethal of all cancers. It is more common in
women and occurs primarily in older patients. ATC has a median overall survival of 3–5 …

Thyroid cancer is an uncommon malignancy that accounts for roughly 1% of all new
cancers. Although anaplastic lesions constitute fewer than 5% of thyroid cancers, they …

Background Anaplastic thyroid cancer is an endocrine malignancy. Its rare and rapidly lethal
disease course has made it challenging to study. Little is known regarding the expression by …

Thyroid cancer incidence is increasing at an alarming rate, almost tripling every decade. In
2017, it was the fifth most common cancer in women. Although the majority of thyroid tumors …

Background Anaplastic thyroid carcinoma (ATC) is one of the most aggressive solid tumors
known to affect humans and carries a dismal prognosis. Our primary aim was to review its …

Simple Summary Anaplastic thyroid carcinoma (ATC) has a dismal prognostic.
Chemotherapy and radiotherapy are the mainstem options for patients with ATC. In selected …